Ally Bridge Group’s Ambrx Biopharma Inc AMAM Stock Holding History

Ally Bridge Group’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-385,383	Closed	-$5.49M	–	32
2023 Q4	$5.49M	Buy	385,383 +104,294	+37%	+$1.19M	3.27%	14
2023 Q3	$3.23M	Buy	+281,089	New	+$3.83M	3.79%	11

Ally Bridge Group's AMAM Position: Q1 2024 in Review

Ally Bridge Group sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 385,383 shares — an estimated $5.49M sold.

Ally Bridge Group first reported a position in AMAM in Q3 2023 and held it in 2 quarters. The position peaked at $5.49M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Ally Bridge Group reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Ally Bridge Group sold 385,383 Ambrx Biopharma Inc shares in Q1 2024, an estimated $5.49M.
Ally Bridge Group first reported a position in Ambrx Biopharma Inc in Q3 2023 and held it in 2 quarters.
Ally Bridge Group's Ambrx Biopharma Inc position peaked at $5.49M in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Ally Bridge Group's 13F filing for Q1 2024, filed 15 May 2024.